Literature DB >> 16679918

Chemokine IL-8 and chemokine receptor CXCR3 and CXCR4 gene expression in childhood acute lymphoblastic leukemia at first relapse.

Shuling Wu1, Reinhard Gessner, Tillmann Taube, Alexander Korte, Arend von Stackelberg, Renate Kirchner, Guenter Henze, Karl Seeger.   

Abstract

In this study, we examined the gene expression of interleukin (IL)-8, CXCR3, and CXCR4 in leukemic cells from 100 children with relapsed B-cell progenitors (BCP) acute lymphoblastic leukemia (ALL), using quantitative real-time polymerase chain reaction (RT-PCR). IL-8, CXCR3, and CXCR4 were expressed in almost all bone marrow (BM) samples. The CXCR4 expression significantly correlated with known prognostic factors at relapse: time point and site of relapse. Patients who had a combined BM relapse (n=21) had lower IL-8 and CXCR4 expression than those who had an isolated BM relapse (n=79). The CXCR3 expression was higher in female patients (n=39) than in male patients (n=61). However, this did not reach prognostic relevance in relapsed ALL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679918     DOI: 10.1097/01.mph.0000212908.14642.a5

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  9 in total

Review 1.  The role of G protein-coupled receptors in lymphoid malignancies.

Authors:  Adrienne Nugent; Richard L Proia
Journal:  Cell Signal       Date:  2017-08-09       Impact factor: 4.315

Review 2.  Chemokines in homeostasis and diseases.

Authors:  Keqiang Chen; Zhiyao Bao; Peng Tang; Wanghua Gong; Teizo Yoshimura; Ji Ming Wang
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 3.  Homeostatic chemokine receptors and organ-specific metastasis.

Authors:  Albert Zlotnik; Amanda M Burkhardt; Bernhard Homey
Journal:  Nat Rev Immunol       Date:  2011-08-25       Impact factor: 53.106

Review 4.  The bone marrow microenvironment and leukemia: biology and therapeutic targeting.

Authors:  Edward Allan R Sison; Patrick Brown
Journal:  Expert Rev Hematol       Date:  2011-06       Impact factor: 2.929

Review 5.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

Review 6.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

Review 7.  Chemokines in tumor progression and metastasis.

Authors:  Purvaba J Sarvaiya; Donna Guo; Ilya Ulasov; Patrik Gabikian; Maciej S Lesniak
Journal:  Oncotarget       Date:  2013-12

Review 8.  Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.

Authors:  Maria Vela; Mariana Aris; Mercedes Llorente; Jose A Garcia-Sanz; Leonor Kremer
Journal:  Front Immunol       Date:  2015-01-30       Impact factor: 7.561

9.  Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous system.

Authors:  Sujeetha A Rajakumar; Ildiko Grandal; Mark D Minden; Johann K Hitzler; Cynthia J Guidos; Jayne S Danska
Journal:  Cell Rep Med       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.